Skip to main content
profile image
Selected Works of Saurabh Vishnubhakat
Article
Has the PTAB Made a Difference in Drug Settlements and Generic Entry?
Nature Biotechnology (2022)
  • Erik Hovenkamp, University of Southern California Gould School of Law
  • Jorge Lemus, University of Illinois Urbana-Champaign
  • Arti Rai, Duke University School of Law
  • Saurabh Vishnubhakat, Benjamin N. Cardozo School of Law
Link
Abstract
Legal barriers are preventing generic drug makers from being able to utilize the Patent Trial and Appeal Board for its intended purpose — to serve as a faster and less cumbersome alternative to district court litigation.
Disciplines
Publication Date
November 8, 2022
DOI
https://doi.org/10.1038/s41587-022-01526-5
Citation Information
Erik Hovenkamp, Jorge Lemus, Arti Rai and Saurabh Vishnubhakat. "Has the PTAB Made a Difference in Drug Settlements and Generic Entry?" Nature Biotechnology Vol. 40 (2022) p. 1569 - 1572
Available at: http://works.bepress.com/saurabh_vishnubhakat/109/